Sort   by:  
 Page size 
0
Genomics,MultiomicsFramingham Cohort

<b>Startup of Framingham Heart Study. Cardiovascular disease (CVD) is the leading cause of death and serious illness in the United States. In 1948, the Framingham Heart Study (FHS) -- under the direction of the National Heart Institute (now known as the National Heart, Lung, and Blood Institut...

phs000007.v17.p6 | EGA
0
GenomicsThe Genomic Landscape of Response to EGFR Blockade in Colorectal Cancer
...common cancer world-wide with 1.2 million patients diagnosed yearly. In late stage CRC, the most commonly used targeted therapies are monoclonal antibodies cetuximab and panitumumab, which inactivate EGFR. Recent studies have identified alterations in KRAS and other genes as likely mechanisms of pr...
EGAS00001001305 | EGA
0
Genomicsena-DATASET-JHUSM-16-11-2015-19:53:19:325-4 - samples
Description not provided
EGAD00001001674 | EGA
0
GenomicsDAC for the study of response to EGFR Blockade in Colorectal Cancer
Data Access Committee EGAC00001000360
EGAC00001000360 | EGA
0
Genomicsena-DATASET-JHUSM-28-09-2015-22:11:53:244-560 - samples
Description not provided
EGAD00001001628 | EGA
1K
OtherJHUSM
Organisation EGAO00000000583
EGAO00000000583 | EGA
Sort   by:  
 Page size